Replies to post #83708 on Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Just a note:

The 8-k includes a European Conference presentation.. and it reflects a LymPro 2016 FDA submission plan. However, LymPro can be commercialized in 2014 as a vitro diagnostic (as long as its CLIA certified...the 2016 FDA submission plan will not create delays in commercializing the product in 2014).

In other words, its a formality once LymPro is CLIA certified.